Answers are grounded in this paper and cite their sources.
Composite inflammatory markers are elevated in specific PCOS phenotypes, especially oligo-/amenorrhea and PCOM, and may reflect low-grade inflammation. These markers may help identify patients at higher cardiometabolic risk and guide preventive strategies.
No takes yet. Share an insight, caveat, or question.
Özkan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: